“Innovation defines our future,” says Enovis R&D Engineering VP Suneethi Gudapati. “We’re never satisfied with the status quo and believe innovation is essential to our success.” In the world of medtech, where advances in material science, engineering, and patient-centered design converge, few companies illustrate the power of continuous improvement quite like Enovis. As one of the largest orthopedic device developers globally, Enovis has earned its reputation not only for surgical solutions but also for its Prevention & Recovery segment. This division, which develops and manufactures bracing and support products, accounts for more than half of the company’s annual sales. At the forefront of this innovation is Suneethi Gudapati, VP of R&D Engineering for U.S. bracing and supports at Enovis. Having joined the company in 2024 after impactful leadership roles at Stryker and Philips, Gudapati brings a unique perspective—one that blends rigorous engineering expertise, entrepreneurial grit, and a passion for reshaping patient outcomes. Beyond stabilization: the hidden potential of bracing products “One underappreciated aspect of bracing and support products is their role beyond stabilization,” Gudapati explained in a recent interview. “They often incorporate graduated compression to improve circulation, have historical roots dating back to the 1500s with innovators like Ambroise Paré, and can redistribute biomechanical loads to facilitate healing or even slow disease progression in custom applications. These devices are essential enablers of mobility and quality of life.” Her insights highlight how bracing technology has evolved from crude supports to advanced medical devices that actively participate in patient rehabilitation. Far from being passive tools, modern braces are designed with performance in mind—helping athletes recover faster, supporting everyday professionals battling back pain, and enabling seniors to maintain mobility longer. A medtech career built on innovation For Gudapati, the path to leading innovation at Enovis has been anything but linear. “My career story is a medtech adventure mixed with a dash of ice cream entrepreneurship,” she joked. Today, based in sunny Carlsbad, California, she leads a team responsible for R&D, project management, and sustaining activities across Enovis’ bracing and supports portfolio. Her role involves much more than overseeing product design. She works closely with stakeholders to identify risks early in the new product introduction (NPI) process, ensuring process discipline improves designs while also driving strategies that enhance productivity without inflating costs. “We’re all about creating bracing and supports products that help people move better, recover faster, and live pain-free,” she explained. The impact of her leadership spans multiple user groups: from knee braces tailored for athletes, to ankle protection designed for recreational runners, to back support systems built for office professionals. For Gudapati, innovation is not about chasing technology for its own sake—it’s about making movement possible, safe, and sustainable for everyone. From India to U.S. medtech leadership Gudapati’s journey reflects resilience and adaptability. She earned her bachelor’s degree from Osmania University in India, followed by a master’s in mechanical engineering from the University of Wisconsin, along with a Project Management Professional (PMP) certification. Her career began in the food service industry at Groen, where she worked on kettles and ovens, before moving into semiconductors at Applied Materials in 2002. After stepping back to focus on raising her children, she embraced entrepreneurship in 2010, running three Subzero Ice Cream franchises. In that venture, she achieved a 30% business growth rate, creatively linking science and food by teaching children how to make ice cream from scratch. “Then medtech called me,” she said. From 2016–2017, Gudapati worked at Stryker, where she led new product releases for defibrillators and addressed complex lithium-ion battery recalls. She then transitioned to Philips, where from 2018 to 2024 she rose from PMO leader for ventilators to senior director of integrated supply chain engineering. In that role, she managed more than 300 team members, resolved FDA issues, and oversaw an unprecedented scale-up in ventilator production during critical global shortages. By 2024, Enovis became the perfect next chapter. “It’s all about turning challenges into breakthroughs,” she said. Bracing evolution: from armor to wearable tech The orthopedic bracing field has transformed dramatically over recent decades. Gudapati traces the lineage from bulky, uncomfortable designs to sleek, high-performance gear. “It’s gone from clunky medieval armor to sleek, smart gear that’s basically wearable tech,” she said. She credits pioneers like Dr. Robert McDavid, who developed the first lateral knee brace in the 1960s, with setting the stage for innovation. The 1980s and 1990s saw usability improvements with Velcro replacing leather straps. The 2000s introduced highly functional designs like dynamic posterior cruciate ligament (PCL) braces, while today’s market embraces waterproof, customizable, and sensor-enabled solutions. This historical context underscores how bracing technology has shifted from reactive to proactive—offering both injury prevention and enhanced recovery capabilities. For patients prescribed orthopedic braces, the journey to recovery does not end once the product is delivered. Clinical effectiveness alone is no longer sufficient; a brace must also be wearable, discreet, and comfortable enough for everyday use. As Suneethi Gudapati explained, Enovis places wearability at the center of its R&D strategy because comfort directly influences compliance. When patients are able to wear their braces without discomfort or disruption to their routines, they are far more likely to follow through with prescribed treatment plans, which in turn improves recovery outcomes. The challenge lies in achieving this balance without compromising safety or support, and it is one that Enovis approaches with careful engineering discipline. One of the most important advances in recent years has been the integration of advanced lightweight materials into product design. Carbon fiber and high-performance polymers have allowed Enovis to create braces that are strong enough to provide stabilization while remaining breathable and unobtrusive. In addition to materials innovation, the use of three-dimensional scanning and additive manufacturing has opened new possibilities for personalization. These technologies allow for custom fits that adapt to the individual patient’s biomechanics, ensuring that braces function as intended while also offering a higher level of comfort. Gudapati emphasized that these innovations do not exist in isolation; they are part of a broader shift toward integrating technology with patient-centered design principles. Another development shaping this space is the growing interest in smart braces that incorporate sensor technology. By embedding sensors into support devices, Enovis is able to generate real-time feedback on movement, alignment, and usage. This benefits clinicians by giving them accurate data on whether patients are complying with treatment, while also empowering patients to actively monitor their progress. It represents a move away from static devices and toward dynamic, data-driven tools that enhance the recovery process. Gudapati noted that this approach aligns closely with her experience streamlining R&D processes, where the goal is to deliver practical innovation that patients will embrace in daily life. The bracing and supports industry is also being reshaped by broader trends in healthcare innovation. Miniaturization has become increasingly important, with devices now expected to be slimmer, sleeker, and less intrusive. Sustainability is another area gaining momentum, as manufacturers explore eco-friendly materials and recyclable polymers to reduce the environmental footprint of medical products. Alongside these shifts, the use of artificial intelligence and machine learning is beginning to influence product development. Predictive models can analyze wear patterns, anticipate points of failure, and recommend design adjustments before prototypes are even built. When combined with 3D printing technologies, this allows companies like Enovis to produce braces that are more adaptive, precise, and patient-specific than ever before. The results of this innovation strategy are already visible in the marketplace. Enovis has launched several groundbreaking products that demonstrate how engineering advances translate into real-world impact. The ROAM OA and Defiance Pro braces, for example, provide targeted solutions for patients managing osteoarthritis or ligament injuries. The Aircast AirSelect Elite features pneumatic compression to support recovery from ankle sprains, while the Exos line offers adjustable, reformable, and waterproof immobilization devices that have redefined the treatment of fractures. At AOSSM 2024, Enovis also introduced new shoulder immobilizers with multi-angle systems designed to optimize post-operative care. Each of these products reflects the company’s commitment to combining performance, protection, and patient experience into every design. While internal innovation remains strong, Gudapati underscored the importance of external collaboration in advancing the field. She expressed particular interest in breakthroughs involving advanced biomaterials that could yield lighter and more biocompatible braces, robotics that enable higher precision in manufacturing, and sustainability technologies that align with the global movement toward greener healthcare. Sensor technologies developed by external partners also remain critical in expanding the intelligence of smart braces. By engaging with startups, research institutions, and suppliers, Enovis positions itself to remain at the forefront of bracing innovation. Looking to the future, Gudapati is most energized by the industry’s shift toward personalized medicine. The ability to design braces that adapt to the unique needs of each patient represents a dramatic leap forward for prevention, treatment, and recovery. Rather than being limited to generic sizes or designs, patients will benefit from individualized solutions that improve comfort, increase compliance, and enhance outcomes. This evolution holds particular promise for addressing chronic conditions, slowing disease progression, and extending mobility for aging populations. For Gudapati, this potential to transform lives is what makes her role at Enovis so rewarding. The convergence of advanced materials, digital health integration, and patient-centered design is pushing orthopedic bracing into a new era. It is no longer enough to provide stabilization; braces must now be intelligent, sustainable, and tailored to individual needs. Enovis’ strategy, shaped by leaders like Gudapati, is to remain ahead of these trends by combining engineering rigor with bold vision. As the industry continues to evolve, the company’s commitment to comfort and compliance ensures that its products do more than support recovery—they help define the future of mobility itself.